Phosphorylated EGFR expression may predict outcome of EGFR-TKIs therapy for the advanced NSCLC patients with wild-type EGFR

<p>Abstract</p> <p>Background</p> <p>EGFR mutation is a strong predictive factor of EGFR-TKIs therapy. However, at least 10% of patients with EGFR wild-type are responsive to TKIs, suggesting that other determinants of outcome besides EGFR mutation might exist. We hypot...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wang Fen, Wang Shuhang, Wang Zhijie, Duan Jianchun, An Tongtong, Zhao Jun, Bai Hua, Wang Jie
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2012-08-01
Colecção:Journal of Experimental & Clinical Cancer Research
Assuntos:
EGFR phosphorylation
EGFR mutation
Non-small cell lung cancer
Acesso em linha:http://www.jeccr.com/content/31/1/65
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados